Abciximab
Links shared publicly online about this topic
Abciximab disappoints in AMI shock in PRAGUE-7
theheart.org — “Seriously ill patients with acute MI complicated by cardiogenic shock did not benefit from the routine use of abciximab during primary PCI, results of the PRAGUE-7 study show.” View full resource at theheart.org
Most Recently Shared on August 31, 2009 at 4:24 pm By:
heartwire: GP IIb/IIIa inhibitor of no benefit in AMI patients with cardiogenic shock http://bit.ly/1EuajE #ESC09
Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction - — JAMA
jama.ama-assn.org — “Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction - — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on March 25, 2012 at 6:41 pm By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Intracoronary Abciximab superior to Aspiration thrombectomy in AMI - http://t.co/BD3gHyrX
Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction - — JAMA
jama.ama-assn.org — “Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction - — JAMA” View full resource at jama.ama-assn.org
Most Recently Shared on March 25, 2012 at 2:04 pm By:
Infusion of #abciximab into coronary artery may help reduce size of heart damage for #heartattack patients. #ACC12 http://t.co/z6aYXN1b
ACC: Bolus Intracoronary Abciximab Reduces Infarct Size --Doctors Lounge
doctorslounge.com — “ACC: Bolus Intracoronary Abciximab Reduces Infarct Size --Doctors Lounge” View full resource at doctorslounge.com
Most Recently Shared on March 26, 2012 at 5:28 pm By:
ACC: Bolus Intracoronary Abciximab Reduces Infarct Size http://t.co/neEbZrZE #Health #Medicine
Intracoronary Abciximab Reduces Size of Large Myocardial Infarcts : Cardiology News
ecardiologynews.com — “Cardiology News is an independent news source that provides cardiologists with timely and relevant news and commentary about clinical developments and the impact of health care policy on cardiology and the cardiologist's practice. Cardiology News Digital Network is the online destination and multimedia properties of Cardiology News, the independent news publication for cardiologists. Cardiology news is the leading source of news and commentary about clinical developments in cardiology as well as” View full resource at ecardiologynews.com
Most Recently Shared on March 26, 2012 at 4:37 pm By:
Bob Finn - Medical News Net Health News
Intracoronary abciximab reduces the size of large myocardial infarcts - http://t.co/Kmjn8kJ2
Early abciximab has benefits in high-risk STEMI patients: study - Cardiology Videos - The Doctor's Channel
thedoctorschannel.com — “Early abciximab has benefits in high-risk STEMI patients: study - Cardiology Videos - The Doctor's Channel” View full resource at thedoctorschannel.com
Most Recently Shared on November 7, 2009 at 9:29 pm By:
Tammi Jacobs Health Professional
Early abciximab has benefits in high-risk STEMI patients: study ... http://bit.ly/1fMJrV
Acute Stent Thrombosis Associated with Heparin-Induced Thrombocytopenia and Abciximab-Induced Profound Thrombocytopenia | Journal of Invasive Cardiology
invasivecardiology.com — “Acute Stent Thrombosis Associated with Heparin-Induced Thrombocytopenia and Abciximab-Induced Profound Thrombocytopenia | Journal of Invasive Cardiology” View full resource at invasivecardiology.com
Most Recently Shared on February 11, 2011 at 2:52 pm By:
Invasive Cardiology Medical Journal and Cardiology
Treatment strategies for concomitant heparin- and abciximab-induced profound thrombocytopenia. http://tinyurl.com/4ubtzgc
ISAR-REACT 4 on bivalirudin; IC vs IV abciximab in AIDA STEMI; vorapaxar in TRACER; ADOPT: apixaban vs enoxaparin; rivaroxaban in ATLAS ACS 2
blogs.theheart.org — “ISAR-REACT 4 on bivalirudin; IC vs IV abciximab in AIDA STEMI; vorapaxar in TRACER; ADOPT: apixaban vs enoxaparin; rivaroxaban in ATLAS ACS 2” View full resource at blogs.theheart.org
Most Recently Shared on November 14, 2011 at 4:33 am By:
Dr Walton-Shirley Physician, Doctor, Internist, and Cardiologist
ISAR-REACT 4 on bivalirudin; IC vs IV abciximab in AIDA STEMI; vorapaxar in TRACER; ADOPT:...: ISAR-REACT 4 on b... http://t.co/NFgpkRaX
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on November 16, 2010 at 1:03 pm By:
CICERO: Mixed results for intracoronary abciximab in STEMI: Intracoronary rather than intravenous administration... http://bit.ly/aKNvCC
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 25, 2012 at 1:31 pm By:
INFUSE-AMI: Intracoronary abciximab, not thrombectomy, reduces infarct size http://t.co/fFlmQE8y #ACC12
American Heart Association: More News, 15-Nov-2010
medicalnewstoday.com — “Abstract 21854 - Direct-to-the-heart platelet inhibitor shows promise for heart attack patientsInjecting a platelet inhibitor directly into the heart through a coronary artery (in” View full resource at medicalnewstoday.com
Most Recently Shared on November 17, 2010 at 12:42 pm By:
American Heart Association: More News, 15-Nov-2010 http://mnt.to/3MFR #blood #hematology
Cardiology Medical News about Coronary Artery Disease
mdlinx.com — “Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease” View full resource at mdlinx.com
Most Recently Shared on May 28, 2010 at 7:51 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Does Abciximab Promote Coronary Artery Remodeling in Patients With Kawasaki Disease: The American J... http://bit.ly/cCLEZy #cardio #mdlinx
Cardiology Medical News about Myocardial Infarction
mdlinx.com — “Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 3:44 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevatio... http://bit.ly/bvj950 #cardio #mdlinx
Internal Medicine Article | Myocardial Infarction
mdlinx.com — “Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration” View full resource at mdlinx.com
Most Recently Shared on November 18, 2010 at 2:46 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myo... http://bit.ly/cLAosj #medicine
Cardiology Article | Myocardial Infarction
mdlinx.com — “Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration” View full resource at mdlinx.com
Most Recently Shared on November 18, 2010 at 8:21 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation M... http://bit.ly/dfyLeY #cardiology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
M Auron MD
Internist and Pediatrician. Hospitalist.
-
JAMA
The Journal of the American Medical Association, published since 1883, is an international peer-reviewed general medical journal published 48 times per year.
Advertisement
